Contribution of LPHN3 to the genetic susceptibility to ADHD in adulthood: a replication study

• Published in: Genes, brain and behavior brain and behavior, 2011-03, Vol.10 (2), p.149-157
• Main Authors: Ribasés, M., Ramos‐Quiroga, J. A., Sánchez‐Mora, C., Bosch, R., Richarte, V., Palomar, G., Gastaminza, X., Bielsa, A., Arcos‐Burgos, M., Muenke, M., Castellanos, F. X., Cormand, B., Bayés, M., Casas, M.
• Format: Article
• Language: English
• Subjects: Adult; Adult ADHD; Amygdala; Attention Deficit Disorder with Hyperactivity - epidemiology; Attention Deficit Disorder with Hyperactivity - genetics; Attention deficit hyperactivity disorder; Case-Control Studies; case–control association study; Caudate nucleus; Cerebellum; Cortex; Diagnostic and Statistical Manual of Mental Disorders; DNA - genetics; DNA - isolation & purification; Female; G protein-coupled receptors; Genetic Markers; Genetic Predisposition to Disease - epidemiology; Genotype; Haplotypes; Humans; Life span; Linkage Disequilibrium; LPHN3; Male; Medical research; Neurodevelopmental disorders; Neuropsychological Tests; Polymorphism, Single Nucleotide; Quality Control; Receptors, G-Protein-Coupled - genetics; Receptors, Peptide - genetics; Replication; Risk factors; Single-nucleotide polymorphism; Spain - epidemiology
• ISSN: 1601-1848; 1601-183X
• DOI: 10.1111/j.1601-183X.2010.00649.x

Attention‐deficit/hyperactivity disorder (ADHD) is a common and highly heritable developmental disorder characterized by a persistent impairing pattern of inattention and/or hyperactivity‐impulsivity. Using families from a genetic isolate, the Paisa population from Colombia, and five independent datasets from four different populations (United States, Germany, Norway and Spain), a highly consistent association was recently reported between ADHD and the latrophilin 3 (LPHN3) gene, a brain‐specific member of the LPHN subfamily of G‐protein‐coupled receptors that is expressed in ADHD‐related regions, such as amygdala, caudate nucleus, cerebellum and cerebral cortex. To replicate the association between LPHN3 and ADHD in adults, we undertook a case–control association study in 334 adult patients with ADHD and 334 controls with 43 single nucleotide polymorphisms (SNPs) covering the LPNH3 gene. Single‐ and multiple‐marker analyses showed additional evidence of association between LPHN3 and combined type ADHD in adulthood [P = 0.0019; df = 1; odds ratio (OR) = 1.82 (1.25–2.70) and P = 5.1e‐05; df = 1; OR = 2.25 (1.52–3.34), respectively]. These results further support the LPHN3 contribution to combined type ADHD, and specifically to the persistent form of the disorder, and point at this new neuronal pathway as a common susceptibility factor for ADHD throughout the lifespan.